Zhu Yi, Wang Donna H
Department of Medicine and Neuroscience Program, Michigan State University, East Lansing, Michigan, USA.
J Cardiovasc Pharmacol. 2008 May;51(5):437-42. doi: 10.1097/FJC.0b013e318168d120.
Our previous studies show that activation of the transient receptor potential vanilloid type 1 (TRPV1) channels by a selective agonist, capsaicin (CAP), given unilaterally into the renal pelvis leads to increases in urine flow rate (Uflow) and urinary sodium excretion (UNa) bilaterally, although the mechanisms underlying enhanced renal excretory function are unknown. The present study was designed to determine the contribution of each of the renal segments to enhanced renal excretory function when TRPV1 expressed in sensory nerve fibers innervating the renal pelvis is activated. To accomplish the goal, LiCl was given intravenously to male Wistar rats while the left renal pelvis (LRP) was perfused with vehicle or CAP with or without a selective TRPV1 antagonist, capsazepine (CAPZ). Uflow and clearance of creatinine, lithium, sodium, and water, either filtered or fractionally, were determined in both kidneys. LRP perfusion of CAP at 2.4 nmol increased Uflow (microL.ming; ipsilaterally from 6.6 +/- 0.6 to 14.6 +/- 2.2 and contralaterally from 7.4 +/- 0.7 to 13.9 +/- 1.8, P < 0.05) and UNa (micromol.ming; ipsilaterally from 0.6 +/- 0.2 to 1.8 +/- 0.3 and contralaterally from 0.7 +/- 0.2 to 1.9 +/- 0.4, P < 0.05). Ipsilateral blockade of the TRPV1 with CAPZ at 24 nmol prevented CAP-induced increases in Uflow and UNa bilaterally. Creatinine, lithium, sodium, and free water clearance (ml.min) were increased in CAP (1.47 +/- 0.27, 0.44 +/- 0.05, 0.026 +/- 0.004, 0.41 +/- 0.05, respectively) compared to vehicle (0.72 +/- 0.12, 0.25 +/- 0.05, 0.010 +/- 0.001, 0.24 +/- 0.05), CAPZ+CAP (0.83 +/- 0.13, 0.24 +/- 0.03, 0.014 +/- 0.002, 0.23 +/- 0.03), and CAPZ (0.88 +/- 0.05, 0.21 +/- 0.01, 0.010 +/- 0.001, 0.20 +/- 0.01) groups (P <or= 0.01). Filtered sodium load, distal delivery of sodium, and distal sodium reabsorption (muEq.min) were also increased in CAP (202.2 +/- 33.3, 61.3 +/- 7.4, 57.6 +/- 7.4, respectively) compared to vehicle (97.7 +/- 16.6, 33.6 +/- 5.8, 32.2 +/- 5.9), CAPZ+CAP (110.5 +/- 16.3, 32.5 +/- 4.5, 30.7 +/- 4.3), and CAPZ (118.0 +/- 4.5, 27.9 +/- 1.2, 26.8 +/- 1.2) groups (P <or= 0.01). In contrast, fractional lithium and sodium excretion, absolute proximal reabsorption, fractional proximal reabsorption, fractional distal sodium, and water reabsorption were not different among groups. Therefore, activation of the TRPV1 expressed in primary afferent nerves innervating the renal pelvis leads to diuresis and natriuresis in both kidneys. The TRPV1-induced sodium and water excretion appears to be mediated by increases in glomerular filtration rate and distal tubular delivery of sodium but not by suppression of renal proximal and distal tubular reabsorption, suggesting a key role of segmental regulation of renal function by TRPV1-positive primary sensory nerves in the maintenance of sodium and water homeostasis.
我们之前的研究表明,通过选择性激动剂辣椒素(CAP)单侧注入肾盂激活瞬时受体电位香草酸亚型1(TRPV1)通道,可导致双侧尿流率(Uflow)和尿钠排泄(UNa)增加,尽管增强肾脏排泄功能的潜在机制尚不清楚。本研究旨在确定当支配肾盂的感觉神经纤维中表达的TRPV1被激活时,每个肾段对增强肾脏排泄功能的贡献。为实现这一目标,给雄性Wistar大鼠静脉注射LiCl,同时用载体或CAP灌注左肾盂(LRP),有无选择性TRPV1拮抗剂辣椒平(CAPZ)。测定了双肾的Uflow以及肌酐、锂、钠和水的清除率,包括滤过清除率或分数清除率。以2.4 nmol的CAP灌注LRP可增加Uflow(微升/分钟;同侧从6.6±0.6增加到14.6±2.2,对侧从7.4±0.7增加到13.9±1.8,P<0.05)和UNa(微摩尔/分钟;同侧从0.6±0.2增加到1.8±0.3,对侧从0.7±0.2增加到1.9±0.4,P<0.05)。用24 nmol的CAPZ同侧阻断TRPV1可双侧阻止CAP诱导的Uflow和UNa增加。与载体组(0.72±0.12、0.25±0.05、0.010±0.001、0.24±0.05)、CAPZ+CAP组(0.83±0.13、0.24±0.03、0.014±0.002、0.23±0.03)和CAPZ组(0.88±0.05、0.21±0.01、0.010±0.001、0.20±0.01)相比,CAP组的肌酐、锂、钠和自由水清除率(毫升/分钟)增加(分别为1.47±0.27、0.44±0.05、0.026±0.004、0.41±0.05)(P≤0.01)。与载体组(97.7±16.6、33.6±5.8、32.2±5.9)、CAPZ+CAP组(110.5±16.3、32.5±4.5、30.7±4.